# OnCo record nct02704858 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02704858/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02704858", "NCT02704858" ;
  schema:name "Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma"@en ;
  schema:description "A phase 1/2 trial of Perillyl alcohol in glioma & glioblastoma, run by Neonc Technologies, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02704858/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02704858> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2017-08-01" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/idh-mutant-astrocytoma/> ;
  onco:companies <https://onco.cc/companies/neonc-technologies/> .